PUBLISHER: Market Research Future | PRODUCT CODE: 1545628
PUBLISHER: Market Research Future | PRODUCT CODE: 1545628
Asia Pacific Lancet and Pen Needles Market Research Report Data by Type (lancets and pen needles), Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (GLP), Skin Testing, and Others), End Use (Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, Research & Academic Laboratories, and Others), by Region (China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific) Forecast to 2032
The Asia Pacific Lancet and Pen Needles Market is projected to grow at a robust rate, with a compound annual growth rate of Lancets are single-use tools/devices used by healthcare providers for limited blood testing. Lancets are an essential component of programs in hospitals, clinics, research facilities, and doctor's offices that aim to prevent sharp injuries. One of the most utilized substitute tools for drawing blood is a lancet. Lancets and pen needles are becoming more and more popular around the world because of their many practical features, which provide them an advantage over more conventional vein puncture techniques. A hollow needle that fits into a plastic hub and fastens to injection pens makes up a pen needle. Injectable drugs are administered into the body using injection pens and pen needles.
The main factors propelling the growth of the Asia-Pacific lancet and pen needles market are the rising rates of diabetes in the region and the market players' strategic initiatives related to pen needles. However, it is anticipated that alternative medication delivery technologies may limit the growth of the Asia-Pacific market. However, it is projected that the Asia-Pacific region's aging population will generate profitable prospects for the industry.
Based on product type, the Asia-Pacific lancet and pen needles market has been divided into two segments: lancets and pen needles.
Based on application, the lancet and pen needle market has been divided into segments such as insulin, hormones, glucose-like peptide (GLP), capillary blood sample, skin testing, and others.
Based on the end user, the lancet and pen needle market is segmented into home care & diagnostics, medical facilities & diagnostic centers, hospitals & clinics, research & academic laboratories, and others.
The Asia-Pacific lancet and pen needle market has been divided into China and India based on country. Australia, South Korea, Japan, and the remaining Asia-Pacific countries. In 2022, China held the biggest market share. Nonetheless, throughout the course of the projection period, India is expected to develop at the greatest CAGR.
Principal Players
Novo Nordisk A/S, Terumo Corporation, B. Braun SE, Nipro Corporation, Abbott, and Cardinal Health are the major industry participants.